Updates to the Management of Patients with Relapsed/Refractory Indolent B-Cell Lymphomas
Oncologists and hematologists need to maintain high awareness of the recently approved targeted therapies and the precise indications for their use so that these can be incorporated in routine clinical practice in the appropriate patient population.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Plenary Session – The Patient Journey: Equity of Cancer Care
Experts will discuss promising and best practices to provide equitable cancer care to sexual, gender, and racial minority patients. The session will also feature an update on the Elevating Cancer Equity initiative as well as policy initiatives focused on improving health equity. Additionally, leading cancer centers will share successful programs they have implemented to engage underserved communities.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Management of Patients with Advanced Melanoma
Despite recent advancements in immunotherapies and targeted therapies for melanoma patients with late stage disease, treatment options for these patients are not limited to systemic therapies. An overview of current challenges facing this patient population, as well as an in-depth analysis of treatment modalities, will be beneficial to the oncology care team.
Category
  • Melanoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Non-Small Cell Lung Cancer: Management of Patients with Resectable Disease
Many patients with stages I to IIIA NSCLC are eligible for surgery followed by adjuvant therapy. Multidisciplinary evaluation is recommended to decide whether patients with stages I to IIIA NSCLC have resectable disease and to determine the most appropriate surgical procedure. The NCCN Guidelines now recommend biomarker testing for EGFR mutations in patients with completely resected stages IB to IIIA NSCLC to determine whether they are eligible for certain adjuvant targeted therapy. Previously, the NCCN Guidelines only recommended biomarker testing for eligible patients with advanced NSCLC.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Targeted Therapy for Patients with Metastatic Non-Small Cell Lung Cancer
The rapid pace of updates to the NCCN Guidelines for NSCLC makes it challenging for health care providers to stay informed about current recommendations, including how to assess for and manage side effects with the newer agents.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Updates to Management of Patients with Multiple Myeloma
To navigate through the complex treatment landscape, physicians and other oncology care providers must understand the evolving therapeutic options and guidelines for administration of the available therapies in the context of the patient's therapeutic and disease history. The increasing complexity of myeloma treatment warrants rigorous efforts to provide adequate supportive care and preserve the quality of life of patients.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Challenging Case Review: Non-Small Cell Lung Cancer
As a result of the therapeutic advances and clinical research affecting the management of patients with non-small cell lung cancer, clinicians can benefit by comparing their individual skills of diagnosis, treatment, and management of patients with their peers. This peer interaction is an integral part in enhancing clinical decision-making skills that can improve patient care.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
State Legislation Addressing Specialty Pharmacy Policy
Payer/pharmacy benefit manager (PBM) intrusion into the patient care continuum is a major risk to quality. Treatment delays as a result of white-bagging policies are increasing in frequency. PBM/payer restrictions have increased and are a potential threat to high-quality guideline concordant care as they could steer patients to less efficacious treatments that cost the health plans less money. As the federal government has been slow to act, having an understanding for how state legislatures have begun to address these issues can help those involved in the care of patients with cancer to work within their cancer community to best address these issues at a local level.
Category
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
New Approaches for the Treatment of Patients with Anal Carcinoma
Anal cancer is rare but increasing in incidence, making education on how to treat advanced or metastatic disease important for clinicians. There have recently been significant, practice-changing developments in systemic therapy options for advanced anal cancer based on clinical trial results and pending FDA approvals, making this a timely topic for discussion.
Category
  • Anal Carcinoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Strategies and Initiatives to Improve New Patient Access to Cancer Care
Many cancer centers operate at or close to full capacity and have difficulty scheduling patient appointments in a timely manner. Delayed patient appointments may directly impact patient outcomes when a patient is unable to seek treatment. A delayed appointment may also cause additional distress for patients who are anxious to schedule treatment.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages